The abstract is read at the publisher; the summary is JClub's.
Five pragmatic randomized trials of routine hemodialysis care used altered consent processes across interventions, showing they can be ethically acceptable while enabling rigorous trial conduct.
- Why it matters: Conventional written consent for every eligible patient can make large pragmatic hemodialysis trials infeasible, limiting evidence on which routine care components improve outcomes.
- What they did: The team described experience from 5 pragmatic randomized trials (dialysate temperature, magnesium, bicarbonate, expanded solute removal, and transplant access), using consent waivers, notification with opt-out, record documentation, and separate consent for selected data.
- The result: When paired with patient notification, opt-out, independent oversight, and safeguards for vulnerability, these consent alterations can remain respectful and transparent while allowing trials that might otherwise not be conducted.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.